ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,173.02
0.64%
Dow Jones
42,544.22
-0.07%
Gold vs US Dollar
2,625.915
0.06%
Brent Oil
73.855
0.00%
Bitcoin
95,066.03
0.72%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Mainz BioMed NV (MYNZ) Share Price

MYNZ Mainz BioMed NV

4.36
-0.20 (-4.39%)
01 Jan 2025 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Mainz BioMed NV NASDAQ:MYNZ NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.20 -4.39 4.36 4.33 4.46 4.73 4.24 4.5 54,740 01:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Testing Laboratories 895k -26.3M - N/A 9.12M
 Type  Size  Price  Time  Units 
 20 110 4.36 00:42:32 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore MYNZ News
19/12/202413:01GLOBEMainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
16/12/202422:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
16/12/202422:00GLOBEMainz Biomed Announces Closing of $8.0 Million Follow-On Offering
16/12/202413:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/12/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
13/12/202405:15EDGAR2Form EFFECT - Notice of Effectiveness
13/12/202401:00GLOBEMainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules
Period
Draw mode
Data Downloads for MYNZ

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Mainz BioMed NV Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads